High prevalence of HTLV-I and HTLV-II among blood donors in Argentina:: A South American health concern

被引:21
作者
Biglione, MM
Astarloa, L
Salomón, HE
机构
[1] Univ Buenos Aires, Fac Med, SIDA, Ctr Nacl Referencia,Dept Microbiol,CNRS, Buenos Aires, DF, Argentina
[2] Minist Salud & Acc Social, Program SIDA, Buenos Aires, DF, Argentina
关键词
D O I
10.1089/aid.2005.21.1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
After an HTLV- I endemic area was discovered in Jujuy, a northwestern province in Argentina, to detect other possible foci of HTLV- I/ II we started in 1997 a multicentric study to estimate the seroprevalence of HTLV- I/ II including blood banks from different regions of the country. Out of 123,233 samples from nine different provinces, 68 proved seropositive with a final prevalence of 0.05% ( 95% CI = 0.0432 - 0.0704%). The seroprevalence ranged from 0.03 to 0.16% depending on the geographic location. An HTLV- I [ odds ratio ( OR) 12.7, 95% confidence interval ( CI), 3.43 - 47.60] prevalence significantly greater was found in the northwest ( Salta Province) and a nonsignificant but higher prevalence of HTLV- II in the North ( Chaco). Two ( 0.001%) of the seropositive blood donors reported risk factors due to receiving transfusions and 19 ( 0.01%) were born in HTLV- I/ II South American endemic areas. Although Argentina has been considered a nonendemic country for HTLV- I/ II, the need for systematic screening for such infection became imperative based on the present study.
引用
收藏
页码:1 / 4
页数:4
相关论文
共 24 条
[1]   High prevalence of HTLV-I infection in Argentinian blood donors: A new HTLV-I-endemic area? [J].
Biglione, M ;
Pizarro, M ;
Crespo, O ;
Severich, I ;
Peralta, LM ;
Libonatti, O ;
Avila, MM ;
Astarloa, L .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1999, 20 (01) :101-102
[2]  
BIGLIONE M, 1993, J ACQ IMMUN DEF SYND, V6, P631
[3]   A cluster of human T-cell lymphotropic virus type I -: Associated myelopathy/tropical spastic paraparesis in Jujuy, Argentina [J].
Biglione, MM ;
Pizarro, M ;
Puca, A ;
Salomón, HE ;
Berría, MI .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 32 (04) :441-445
[4]  
BLATTNER WA, 1989, ANN INTERN MED, V1, P4
[5]   HTLV TYPE-I AND HTLV TYPE-II INFECTION AMONG INDIANS AND NATIVES FROM ARGENTINA [J].
BOUZAS, MB ;
ZAPIOLA, I ;
QUIRUELAS, S ;
GORVEIN, D ;
PANZITA, A ;
REY, J ;
CARNESE, FP ;
CORRAL, R ;
PEREZ, C ;
ZALA, C ;
GALLO, D ;
HANSON, CV ;
MUCHINIK, G .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (11) :1567-1571
[6]  
CARTIERROVIROSA L, 1989, LANCET, V1, P556
[7]  
CENSABELLA M, 1999, LENGUAS INDIGENAS AR, P47
[8]  
DELPINO N, 1994, J ACQ IMMUN DEF SYND, V7, P206
[9]  
Dipierri JE, 1999, MEDICINA-BUENOS AIRE, V59, P717
[10]   Endemic infection with human T cell leukemia/lymphoma virus type IIB in Argentinean and Paraguayan Indians: Epidemiology and molecular characterization [J].
Ferrer, JF ;
Esteban, E ;
Dube, S ;
Basombrio, MA ;
Segovia, A ;
PeraltaRamos, M ;
Dube, DK ;
Sayre, K ;
Aguayo, N ;
Hengst, J ;
Poiesz, BJ .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (05) :944-953